Sharvil Patel

Rediff.com » News » Sharvil Patel

News for Sharvil Patel

News
Business

Does India have enough jabs to expand vaccination drive?

A back of the envelope calculation shows that India has roughly over 680 million doses of Covid-19 vaccines consisting primarily of Covishield, reports Sohini Das. IMAGE: People line up for the......

India's vaccine makers prepare to take on Omicron

As the Omicron variant of Sars-CoV-2 takes centrestage, vaccine makers in India are of the view that scaling up the existing vaccines to make them more effective is possible. IMAGE: A lady shows......

Govt developing multi-variant Covid-19 vaccine

Government institutions and pharma industry are examining if a 'cocktail' approach to making a multi-variant Covid-19 vaccine works against multiple strains of the ever-mutating virus,......

3rd wave: Govt creating 30-day stock of key Covid medicines

'The Centre is planning to procure five million vials of Remdesivir ahead of the third wave. What’s better is that this time, the government is paying us in advance,' said a senior executive......

Zydus Cadila to begin vaccine trials for kids above 5 yrs soon

So far, no other vaccine has been approved globally for children below 12 years.Sohini Das reports. IMAGE: A beneficiary receives a dose of the Covid-19 vaccine at a vaccination centre in......

Zydus gets China nod for kidney disease drug

Ahmedabad-based Zydus Lifesciences said on Tuesday that a new drug application for its oral drug Desidustat used in treating anaemia in chronic kidney disease (CKD) patients had been accepted by......

US drug shortage a shot in the arm for Indian pharmaceutical companies

Drug shortages in the US are at an all-time high, and price erosion has stabilised, which could benefit Indian pharmaceutical (pharma) companies with a US focus, according to analysts. Image used......

Cadila believes it has silver bullet to fight COVID-19

Can Interferon alfa-2b treat COVID-19 effectively?Sohini Dutt reports. Kindly note the image has been posted only for representational purposes. Photograph: PTI Photo Ahmedabad-based......

Sun Pharma's Dilip Shanghvi takes 99% pay cut

As on July 31, the valuation of his shareholding in the company stood at Rs 9,830 crore. The founder and managing director (MD) of the country’s largest pharmaceutical firm Sun......

'It was very hard to build an R&D set-up in India'

'In any organisation, a continuous line of leadership, is required.' 'All R&D will be of focus. All the way from Active Pharmaceutical Ingredients to R&D in formulations, to biologics, NCEs,......

Rediff News

Sharvil Patel

News for Sharvil Patel

Does India have enough jabs to expand vaccination drive?

India's vaccine makers prepare to take on Omicron

Govt developing multi-variant Covid-19 vaccine

3rd wave: Govt creating 30-day stock of key Covid medicines

Zydus Cadila to begin vaccine trials for kids above 5 yrs soon

Zydus gets China nod for kidney disease drug

US drug shortage a shot in the arm for Indian pharmaceutical companies

Cadila believes it has silver bullet to fight COVID-19

Sun Pharma's Dilip Shanghvi takes 99% pay cut

'It was very hard to build an R&D set-up in India'

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS